Cargando...

Efficacy of Oritavancin in a Murine Model of Bacillus anthracis Spore Inhalation Anthrax

The inhaled form of Bacillus anthracis infection may be fatal to humans. The current standard of care for inhalational anthrax postexposure prophylaxis is ciprofloxacin therapy twice daily for 60 days. The potent in vitro activity of oritavancin, a semisynthetic lipoglycopeptide, against B. anthraci...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heine, H. S., Bassett, J., Miller, L., Bassett, A., Ivins, B. E., Lehoux, D., Arhin, F. F., Parr, T. R., Moeck, G.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2008
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533456/
https://ncbi.nlm.nih.gov/pubmed/18606841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00360-08
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!